Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

Abstract Cognitive post‐acute sequelae of SARS‐CoV‐2 (PASC) can occur after mild COVID‐19. Detailed clinical characterizations may inform pathogenesis. We evaluated 22 adults reporting cognitive PASC and 10 not reporting cognitive symptoms after mild SARS‐CoV‐2 infection through structured interview...

Full description

Bibliographic Details
Main Authors:	Alexandra C. Apple, Alexis Oddi, Michael J. Peluso, Breton M. Asken, Timothy J. Henrich, J. Daniel Kelly, Samuel J. Pleasure, Steven G. Deeks, Isabel Elaine Allen, Jeffrey N. Martin, Lishomwa C. Ndhlovu, Bruce L. Miller, Melanie L. Stephens, Joanna Hellmuth
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.51498

Similar Items

Circulating plasma-derived extracellular vesicles expressing bone and kidney markers are associated with neurocognitive impairment in people living with HIV
by: Erika G. Marques de Menezes, et al.
Published: (2024-04-01)

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
by: Katie E. Osborn, et al.
Published: (2019-12-01)

Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review
by: Breton M. Asken, et al.
Published: (2021-05-01)

Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation
by: Da Cheng, et al.
Published: (2022-02-01)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
by: Michael J. Peluso, et al.
Published: (2020-01-01)

Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease
by: R. López-Cuevas, et al.
Published: (2023-05-01)

Detecting mild neuroinflammation in the cerebrospinal fluid of patients with psychosis
by: Kimon Runge, et al.
Published: (2023-04-01)

Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment
by: Erika G. Marques de Menezes, et al.
Published: (2022-12-01)

Clinical and Cerebrospinal Fluid Abnormalities as Diagnostic Tools of Tuberculous Meningitis
by: Fiona Lestari, et al.
Published: (2016-03-01)

Abnormal visual search in mild cognitive impairment and Alzheimer's disease.
by: Tales, A, et al.
Published: (2005)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
by: Pieter Jelle Visser, et al.
Published: (2022-03-01)

PET tau and amyloid-β burden in mild Alzheimer's disease: divergent relationship with age, cognition and cerebrospinal fluid biomarkers
by: Koychev, I, et al.
Published: (2017)

The latent HIV reservoir: current advances in genetic sequencing approaches
by: Preeti Moar, et al.
Published: (2023-10-01)

Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy
by: Thomas A. Premeaux, et al.
Published: (2020-06-01)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
by: Pieter Jelle Visser, et al.
Published: (2022-05-01)

Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment
by: Petropoulos Christos J, et al.
Published: (2005-11-01)

A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity
by: Scott Bowler, et al.
Published: (2022-10-01)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
by: Jung Eun Park, et al.
Published: (2019-03-01)

Cerebrospinal fluid abnormalities in meningeosis neoplastica: a retrospective 12-year analysis
by: Marija Djukic, et al.
Published: (2017-03-01)

Test Your Knowledge: Ten Questions about Abnormal Cerebrospinal Fluid Results
Published: (2004-01-01)

Retinal abnormalities in multiple sclerosis patients with associated chronic cerebrospinal venous insufficiency
by: Aneta Adamczyk-Ludyga, et al.
Published: (2012-06-01)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
by: Marco Vinceti, et al.
Published: (2017-12-01)

Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment
by: Angela J. Hanson, et al.
Published: (2023-04-01)

High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury
by: Charles W. Wilkinson, et al.
Published: (2012-02-01)

Praziquantel in the cerebrospinal fluid in neurocysticercosis
by: A. Spina-França, et al.
Published: (1985-09-01)

Magnetoencephalography abnormalities in adult mild traumatic brain injury: A systematic review
by: Christopher M. Allen, et al.
Published: (2021-01-01)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
by: Suzanne M. de la Monte, et al.
Published: (2023-08-01)

Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection
by: Michelle L. D'Antoni, et al.
Published: (2019-11-01)

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
by: Ahmad, S, et al.
Published: (2024)

Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
by: Niels Hansen, et al.
Published: (2023-01-01)

Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
by: Aida Kamalian, et al.
Published: (2023-07-01)

Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer's disease.
by: Tales, A, et al.
Published: (2005)

Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis
by: Atmakuri RM, et al.
Published: (2006-06-01)

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy
by: M. Peluso, et al.
Published: (2019-12-01)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
by: J. M. Hatcher-Martin, et al.
Published: (2021-11-01)

Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis
by: J. Matías-Guiu, et al.
Published: (2010-01-01)

The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory
by: Yuan Li, et al.
Published: (2019-08-01)

Reply to the Letter: “Abnormal cerebrospinal fluid composition can accompany CNS involvement in COVID-19”
by: Renan Barros Domingues, et al.
Published: (2022-09-01)

Abnormal cerebrospinal fluid composition can accompany central nervous system involvement in COVID-19
by: Josef Finsterer, et al.
Published: (2022-09-01)

Hyperphosphatasia with mental retardation syndrome 3: Cerebrospinal fluid abnormalities and correction with pyridoxine and Folinic acid
by: Martina Messina, et al.
Published: (2023-01-01)